in this double-blind study versus placebo , the anti-migraine efficacy of flunarizine 20 mg/per os/day for 14 days , followed by 10 mg/per os/day up to 120 days has been evaluated in 30 patients suffering from common and classical migraine .
C0149931
migraine
C0154723
classical